Sustained release ophthalmic drug dosage

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4271143
SERIAL NO

06037314

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to an aqueous dispersion of an ophthalmic drug and a high molecular weight polymer which forms a highly viscous gel and can be used to prolong the duration of activity of the ophthalmic drug when the gel is applied into the conjunctival sac of the eye. The ophthalmic drug-containing gel composition has prolonged retention time in the eye and remains in contact with the surface of the eye for an extended period of time.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ALCON LABORATORIES, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Roehrs, Robert E Fort Worth, TX 9 543
Schoenwald, Ronald D Fort Worth, TX 30 345

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation